On the upside
Delta Air Lines (NYSE: DAL) will bring back flights between Pittsburgh and Paris for one year in 2013.
FONAR (Nasdaq: FONR) reported sharply higher earnings for fiscal 2012 compared with fiscal 2011.
On the downside
Concerns arose over the effectiveness of Threshold Pharmaceuticals' (Nasdaq: THLD) pancreatic cancer treatment TH-302.
Standard & Poor's lifted its corporate credit rating on Pentair (NYSE: PNR) to BBB from BBB- but the stock price fell.
EdR (NYSE: EDR) reported that same-community opening occupancy rate for 2013-2013 dropped to 90.5% from 94.7% the previous year.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 4 on Nasdaq. The Russell 2000 which tracks small cap stocks edged up a fraction to 838.